Live feed09:00:00·1880dPRReleasevia QuantisnowImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.ByQuantisnow·Wall Street's wire, on your screen.NK· NantKwest, Inc.Health CareOriginal source
